Intensity-modulated radiation therapy (IMRT): Toward a new standard for radiation therapy of head and neck cancer?

European Annals of Otorhinolaryngology, Head and Neck Diseases

Volumn 128, Issue 5, 2011, Pages 241-247

  Daly Schveitzer, N ^a   Julieron M ^a   Gan Tao, Y ^a   Moussier, A ^a   Bourhis, J ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Head and neck cancer; IMRT; Intensity modulated; Radiation therapy; Saliva

Indexed keywords

CETUXIMAB;

ARTICLE; CANCER CONTROL; COLLIMATOR; DOSE RESPONSE; DRUG DOSE ESCALATION; FRACTIONATION; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PRIORITY JOURNAL; SALIVARY GLAND; XEROSTOMIA;

EID: 80755128219     PISSN: 18797296     EISSN: 1879730X     Source Type: Journal    
DOI: 10.1016/j.anorl.2011.04.001     Document Type: Short Survey

References (30)

1. J. Thariat, N. Guevara, and P.Y. Marcy Préservation salivaire et nouvelles techniques d'irradiation externe de la tête et du cou Ann Fr Otorhinolaryngol Pathol Cervicofac 127 2010 255 262
2. S.L. Wolden, M.J. Zelefsky, and M.A. Hunt Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 49 2001 1229 1234 (Pubitemid 32294301)
3. M.E. Daly, Q.T. Le, and P.G. Maxim Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure Int J Radiat Oncol Biol Phys 76 2010 1339 1346
4. G.O. Schoenfeld, R.J. Amdur, and C.G. Morris Patterns of failure and toxicity after intensity-modulated radiotherapy for head-and-neck cancer Int J Radiat Oncol Biol Phys 71 2008 377 385
5. K.K. Fu, T.F. Pajak, and A. Trotti A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head-and-neck squamous-cell carcinomas: first report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16 (Pubitemid 30488207)
6. E.J. Hall, and A.J. Giaccia Radiobiology for the radiologist 6th ed. 2006 Lippincott Williams and Wilkins Philadelphia 1-546
7. J.C. Horiot, R. Le Fur, and T. N'Guyen Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy Radiother Oncol 25 1992 231 241 (Pubitemid 23000765)
8. J.C. Horiot, P. Bontemps, and W. van den Bogaert Accelerated fractionation (AF) compared to conventional fractionation (CF) improves locoregional control in the radiotherapy of advanced head-and-neck cancers: results of the EORTC 22851 randomized trial Radiother Oncol 44 1997 111 121 (Pubitemid 27345198)
9. R. Mohan, Q. Wu, and M. Manning Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head-and-neck cancers Int J Radiat Oncol Biol Phys 46 2000 619 630 (Pubitemid 30100639)
10. D.J. Adelstein, Y. Li, and G.L. Adams An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous-cell head-and-neck cancer J Clin Oncol 21 2003 92 98
11. M. Al-Sarraf, M. LeBlanc, and P.G. Giri Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099 J Clin Oncol 16 1998 1310 1317 (Pubitemid 28175745)
12. J.S. Cooper, T.F. Pajak, and A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head-and-neck N Engl J Med 350 2004 1937 1944
13. A.A. Forastiere, H. Goepfert, and M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098 (Pubitemid 37464533)
14. F.F. de Arruda, D.R. Puri, and J. Zhung Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the memorial Sloan-Kettering cancer center experience Int J Radiat Oncol Biol Phys 64 2006 363 373 (Pubitemid 43083420)
15. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head-and-neck N Engl J Med 354 2006 567 578 (Pubitemid 43209104)
16. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for locoregionally advanced head-and-neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival Lancet Oncol 11 2010 21 28
17. N. Lee, P. Xia, and J.M. Quivey Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience Int J Radiat Oncol Biol Phys 53 2002 12 22 (Pubitemid 34465802)
18. K.S. Chao, J.O. Deasy, and J. Markman A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results Int J Radiat Oncol Biol Phys 49 2001 907 916 (Pubitemid 32184597)
19. A. Lin, H.M. Kim, and J.E. Terrell Quality of life after parotid-sparing IMRT for head-and neck cancer: a prospective longitudinal study Int J Radiat Oncol Biol Phys 57 2003 61 70 (Pubitemid 36959739)
20. A. Eisbruch, H.M. Kim, and J.E. Terrell Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer Int J Radiat Oncol Biol Phys 50 2001 695 704 (Pubitemid 32515326)
21. A. Eisbruch, J.A. Ship, and L.A. Dawson Salivary gland sparing and improved target irradiation by conformal and intensity-modulated irradiation of head-and-neck cancer World J Surg 27 2003 832 837 (Pubitemid 37022398)
22. M.K. Kam, S.F. Leung, and B. Zee Prospective randomized studyof intensity-modulated radiotherapy on salivary gland function inearly-stage nasopharyngeal carcinoma patients J Clin Oncol 25 2007 4873 4879 (Pubitemid 350220416)
23. C.M. Nutting, J.P. Morden, and K.J. Harrington Parotid-sparing intensity modulated versus conventional radiotherapy in head-and-neck cancer (PARSPORT): a phase 3 multicentre randomized controlled trial Lancet Oncol 12 2011 127 136
24. F. Claus, T. Boterberg, and P. Ost Postoperative radiotherapy for adenocarcinoma of the ethmoid sinuses: treatment results for 47 patients Int J Radiat Oncol Biol Phys 54 2002 1089 1094 (Pubitemid 35292621)
25. F. Claus, T. Boterberg, and P. Ost Short term toxicity profile for 32 sinonasal cancer patients treated with IMRT. Can we avoid dry eye syndrome? Radiother Oncol 64 2002 205 208 (Pubitemid 35247899)
26. A. Eisbruch, M. Schwartz, and C. Rasch Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 60 2004 1425 1439 (Pubitemid 39601860)
27. K.S. Chao, G. Ozyigit, and B.N. Tran Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer Int J Radiat Oncol Biol Phys 55 1 2003 312 321 (Pubitemid 36069088)
28. G. Sanguineti, L.R. Culp, and E.J. Endres Are neck nodal volumes drawn on CT slices covered by standard three-field technique? Int J Radiat Oncol Biol Phys 59 2004 725 742 (Pubitemid 38748738)
29. D.M. Cannon, and N.Y. Lee Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head-and-neck cancer Int J Radiat Oncol Biol Phys 70 2008 660 665 (Pubitemid 351199716)
30. M.J. Bonastre, E. Noël, and R.J. Bensadoun Le coût de la radiothérapie conformationnelle avec modulation d'intensité dans les cancers ORL : l'étude STIC 2002 Bull Cancer 9 2006 1026 1032 (Pubitemid 44744620)